Parents of children with cancer have additional worries during COVID

February 22, 2021

DURHAM, N.C. - The COVID-19 pandemic has heaped additional financial strains, childcare complications and other problems on already-burdened caregivers of children diagnosed with cancer, according to a study from researchers at Duke Health and other institutions.

Surveying 360 parents and caregivers of children currently in treatment or still being monitored for cancer, the researchers found that half had to cancel or delay appointments, 77% reported increased feelings of anxiety and of those who had lost jobs or wages, 11% struggled to pay for basic needs.

The survey findings appear online this month in the journal Pediatric Blood & Cancer.

"Parents and caregivers of children who have cancer are already under tremendous stress," said lead author Kyle Walsh, Ph.D., associate professor in the Department of Neurosurgery at Duke University School of Medicine. "And while the pandemic has impacted everyone, the isolation, job losses, reduced wages, school closings and other effects of the pandemic have hit families whose children have cancer especially hard."

Walsh and colleagues conducted a 13-question multiple-choice survey in the early months of the pandemic, between April and May 2020, in partnership with the Alex's Lemonade Stand Foundation. The foundation maintains a volunteer registry of families who have children diagnosed with cancer, and caregivers from this registry were the survey participants.

Among those responding, slightly more than half had children currently in treatment or still under surveillance for cancer. Most respondents were women, and household incomes were broadly representative, with about 20% earning incomes of less than $50,000 a year and 30% earning incomes above $100,000 a year.

The study found: "Overall, many families were really struggling with interruptions to care as well as educational disruptions," Walsh said. "In families with more than one child, figuring out how to get their cancer patient to doctor or clinical visits, for example, was complicated by having other children home from school, yet those children could not come along to appointments because of visitor limitations at hospitals and clinics."

Additional concerns focused on how COVID might specifically impact children whose immune systems were already weakened from cancer treatments, and whether additional cleaning and disinfecting routines would be sufficiently protective.

Walsh said another theme that arose from the survey respondents was the numerous commonalities between parenting during their child's treatment and parenting during COVID, particularly being on "high alert" for germs during both periods, notably disinfecting surfaces and restricting visitors.

Walsh said the information gathered in the survey will be helpful in determining how to improve outreach and social support for pediatric cancer patients and their families.

"This idea of trying to identify stress - where social work teams can intervene - will be helpful moving forward," Walsh said. "We understand that everybody is feeling stress and distress with COVID, but this a uniquely at-risk population of children and parents and we need to make a more concerted effort to identify and alleviate this distress to the best we can."
In addition to Walsh, study authors include Courtney E. Wimberly, Lisa Towry, Caroline Caudill and Emily E. Johnston.

The study received funding from Alex's Lemonade Stand Foundation, the National Institutes of Health (R21CA242439-01) and The Children's Health and Discovery Initiative of Translating Duke Health.

Duke University Medical Center

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to